SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001626199-24-000064
Filing Date
2024-05-09
Accepted
2024-05-09 16:22:25
Documents
61
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alpn-20240331.htm   iXBRL 10-Q 1288528
2 EX-31.1 alpn-ex311_20240331.htm EX-31.1 8947
3 EX-31.2 alpn-ex312_20240331.htm EX-31.2 8889
4 EX-32.1 alpn-ex321_20240331.htm EX-32.1 6065
5 EX-32.2 alpn-ex322_20240331.htm EX-32.2 6223
  Complete submission text file 0001626199-24-000064.txt   5230973

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alpn-20240331.xsd EX-101.SCH 33122
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alpn-20240331_cal.xml EX-101.CAL 50717
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alpn-20240331_def.xml EX-101.DEF 135908
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alpn-20240331_lab.xml EX-101.LAB 445554
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alpn-20240331_pre.xml EX-101.PRE 301475
64 EXTRACTED XBRL INSTANCE DOCUMENT alpn-20240331_htm.xml XML 578892
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37449 | Film No.: 24931076
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)